University Heights, OH (PRWEB) May 07, 2012
In recent papers from Italy, Russia and the US, scientists have described the possible benefits of melatonin in avoiding and treating Alzheimer’s disease. Wearing special glasses that block the blue light known to suppress melatonin allows it to flow as if in darkness. In this way the glasses available at LowBlueLights.com allow the body to produce melatonin for the 11-12 hours known to be possible. Because of exposure to light in the hours before bedtime, most Americans only make melatonin for 7 or 8 hours a night.
A recent study(1) of the spinal fluid that bathes the brain suggests this difference in the time that the pineal gland makes melatonin (and other antioxidants) may reduce the probability for the formation of the plaques (2) associated with Alzheimer’s disease. Studies in animals and humans show that the concentration of melatonin in the spinal fluid is significantly higher than in the blood. Melatonin is thought to be the unique antioxidant that protects the brain from damage by eliminating the free radicals that can damage the brain cells.
For information contact Richard L. Hansler PhD 216 397 1657 or rhansler(at)jcu(dot)edu.
Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system. PMID: 21358967 [Pubmed
Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease.PMID: 21358971 [PubMed